Company Filing History:
Years Active: 2016-2018
Title: Sivan Elhanati: Innovator in Age-Related Disease Treatment
Introduction
Sivan Elhanati is a prominent inventor based in Petach Tikva, Israel. She has made significant contributions to the field of biomedical research, particularly in the treatment of age-related diseases. With a total of 3 patents, her work focuses on the modulation of the SIRT6 protein, which has implications for extending lifespan and improving health in mammals.
Latest Patents
One of Sivan Elhanati's latest patents involves the treatment of disease by modulation of SIRT6. This invention aims to provide treatment for age-related diseases by either increasing or decreasing the activity of the SIRT6 protein. The research indicates that mice with over-expressed SIRT6 exhibit a longer lifespan compared to control mice. This finding suggests that enhancing SIRT6 expression could potentially lengthen the lifespan of mammals. The patent identifies agents that can modulate SIRT6 expression, such as those that bind to the 3'UTR region of human mRNA encoding SIRT6 or those that block the binding of other agents to this region.
Career Highlights
Sivan Elhanati is affiliated with Bar-Ilan University, where she continues her research and innovation in the field of age-related diseases. Her work has garnered attention for its potential impact on health and longevity.
Collaborations
Sivan collaborates with notable colleagues, including Haim Yosef Cohen and Yariv Kanfi, who contribute to her research endeavors.
Conclusion
Sivan Elhanati's innovative work in the modulation of SIRT6 protein represents a significant advancement in the treatment of age-related diseases. Her contributions have the potential to improve health outcomes and extend lifespan in mammals.